2m 2m 2m 2m 2m 2m 2m
OS THERAP (OSTX)
NYSE
$1.54-$0.05 (-3.14%)
Price as of Aug 21, 2026 7:59 PM EDT- $73.3MMarket Cap
- -35.89%1-Year Change
- BiotechnologyIndustry
OS THERAP (OSTX)
$1.54-$0.05 (-3.14%)
OSTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.59 | ||
Change | +$0.01 (+0.63%) | ||
Open | $1.56 | ||
High | $1.64 | ||
Low | $1.56 | ||
Previous Close | $1.58 | ||
Volume | 386,419 | ||
30-Day Average Volume | 322,317 | ||
1-Week Change | -1.85% | ||
1-Month Change | 1.92% | ||
1-Year Change | -35.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 46.1M | ||
Total Assets | $9.9M | ||
Market Cap | $73.3M | ||
Enterprise Value | $76.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.6M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$8.6M | ||
EBITDA | -$8.5M | ||
Net Working Capital | -$17.0M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -6 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue